Top

Published in:

01-12-2017 | Nephrology - Review

Peritoneal dialysis-related infections recommendations: 2016 update. What is new?

Authors: Vassilios Liakopoulos, Olga Nikitidou, Theofanis Kalathas, Stefanos Roumeliotis, Marios Salmas, Theodoros Eleftheriadis

Published in: International Urology and Nephrology | Issue 12/2017

Abstract

In 2016, the International Society of Peritoneal Dialysis (ISPD) published guidelines that focus on the importance of both prevention and treatment of peritonitis. For once more, the need for annual reporting of peritonitis rates and recording of peritonitis and exit-site infections, isolated microorganism and antimicrobial susceptibilities as a central component of a quality improvement program is highlighted. Data on new antibiotic regimens, techniques for microorganism isolation and peritoneal dialysis solutions are included. Training of both peritoneal dialysis nurses and patients seems to be crucial, while the modifiable risk factors for peritonitis seem to be of great interest. In this article, we record the changes in the last ISPD (2016) guidelines compared to the previous ones published in 2010.

Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW (2016) ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36(5):481–508. doi:10.3747/pdi.2016.00078 PubMedCrossRef

Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L, Committee IAHA (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25(2):107–131PubMed

Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG, International Society for Peritoneal D (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30(4):393–423. doi:10.3747/pdi.2010.00049 PubMedCrossRef

Nikitidou O, Liakopoulos V, Kiparissi T, Divani M, Leivaditis K, Dombros N (2012) Peritoneal dialysis-related infections recommendations: 2010 update. What is new? Int Urol Nephrol 44(2):593–600. doi:10.1007/s11255-011-9995-9 PubMedCrossRef

Nishina M, Yanagi H, Kakuta T, Endoh M, Fukagawa M, Takagi A (2014) A 10-year retrospective cohort study on the risk factors for peritoneal dialysis-related peritonitis: a single-center study at Tokai University Hospital. Clin Exp Nephrol 18(4):649–654. doi:10.1007/s10157-013-0872-y PubMedCrossRef

Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA (2017) ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int 37(2):141–154. doi:10.3747/pdi.2016.00120 PubMedCrossRef

Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC (2004) Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 44(4):591–603PubMedCrossRef

Hagen SM, Lafranca JA, IJzermans JN, Dor FJ (2014) A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival. Kidney Int 85(4):920–932. doi:10.1038/ki.2013.365 PubMedCrossRef

Eklund B, Honkanen E, Kyllonen L, Salmela K, Kala AR (1997) Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 12(12):2664–2666PubMedCrossRef

10.

Lo WK, Lui SL, Li FK, Choy BY, Lam MF, Tse KC, Yip TP, Ng FS, Lam SC, Chu WL, Cheng SW (2003) A prospective randomized study on three different peritoneal dialysis catheters. Perit Dial Int 23(Suppl 2):S127–131PubMed

11.

Daly C, Cody JD, Khan I, Rabindranath KS, Vale L, Wallace SA (2014) Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease. Cochrane Database Syst Rev 8:CD003078. doi:10.1002/14651858.CD003078.pub2

12.

Figueiredo AE, Bernardini J, Bowes E, Hiramatsu M, Price V, Su C, Walker R, Brunier G (2016) A syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int 36(6):592–605. doi:10.3747/pdi.2015.00277 PubMedCrossRef

13.

Ellis EN, Blaszak C, Wright S, Van Lierop A (2012) Effectiveness of home visits to pediatric peritoneal dialysis patients. Perit Dial Int 32(4):419–423. doi:10.3747/pdi.2010.00145 PubMedPubMedCentralCrossRef

14.

Liakopoulos V, Leivaditis K, Nikitidou O, Divani M, Antoniadi G, Dombros N (2012) Intermittent intraperitoneal dose of teicoplanin in peritoneal dialysis-related peritonitis. Perit Dial Int 32(3):365–366. doi:10.3747/pdi.2011.00171 PubMedPubMedCentralCrossRef

15.

Bordin G, Casati M, Sicolo N, Zuccherato N, Eduati V (2007) Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 33(4):165–171PubMedCrossRef

16.

Ljungman S Prevention of peritonnitis in peritoneal dialysis (PEPS). https://clinicaltrials.gov/ct2/show/results/NCT01293799

17.

Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi M, Tan SH, Voss D (2012) Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 23(6):1097–1107. doi:10.1681/ASN.2011121201 PubMedPubMedCentralCrossRef

18.

Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ (2013) The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int 84(5):969–979. doi:10.1038/ki.2013.190 PubMedCrossRef

19.

Lloyd A, Tangri N, Shafer LA, Rigatto C, Perl J, Komenda P, Sood MM (2013) The risk of peritonitis after an exit site infection: a time-matched, case-control study. Nephrol Dial Transplant 28(7):1915–1921. doi:10.1093/ndt/gft002 PubMedCrossRef

20.

Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC (2011) ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31(6):614–630. doi:10.3747/pdi.2011.00057 PubMedCrossRef

21.

Davenport A (2012) Pan Thames Renal Audit Peritoneal Dialysis Group. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. J Nephrol 25(5):819–824. doi:10.5301/jn.5000071 PubMedCrossRef

22.

Wong C, Luk IW, Ip M, You JH (2014) Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: a cost-effectiveness analysis. Am J Infect Control 42(4):412–416. doi:10.1016/j.ajic.2013.12.008 PubMedCrossRef

23.

Chua AN, Goldstein SL, Bell D, Brewer ED (2009) Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol 4(12):1939–1943. doi:10.2215/CJN.02770409 PubMedPubMedCentralCrossRef

24.

Al-Hwiesh AK, Abdul-Rahman IS, Al-Muhanna FA, Al-Sulaiman MH, Al-Jondebi MS, Divino-Filho JC (2013) Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance. Int J Artif Organs 36(7):473–483. doi:10.5301/ijao.5000207 PubMedCrossRef

25.

Aykut S, Caner C, Ozkan G, Ali C, Tugba A, Zeynep G, Taner C (2010) Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience. Ren Fail 32(3):356–361. doi:10.3109/08860221003611703 PubMedCrossRef

26.

Piraino B (2010) Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective? Nephrol Dial Transplant 25(2):349–352. doi:10.1093/ndt/gfp615 PubMedCrossRef

27.

Lo MW, Mak SK, Wong YY, Lo KC, Chan SF, Tong GM, Lo KY, Wong PN, Tse CW, Kam KM, Wong AK (2013) Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int 33(3):267–272. doi:10.3747/pdi.2011.00184 PubMedPubMedCentralCrossRef

28.

Johnson DW, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Group HSC (2014) Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis 14(1):23–30. doi:10.1016/S1473-3099(13)70258-5 PubMedCrossRef

29.

McQuillan RF, Chiu E, Nessim S, Lok CE, Roscoe JM, Tam P, Jassal SV (2012) A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol 7(2):297–303. doi:10.2215/CJN.07970811 PubMedPubMedCentralCrossRef

30.

Wu HH, Li IJ, Weng CH, Lee CC, Chen YC, Chang MY, Fang JT, Hung CC, Yang CW, Tian YC (2013) Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients. PLoS ONE 8(8):e71532. doi:10.1371/journal.pone.0071532 PubMedPubMedCentralCrossRef

31.

Su CY, Pei J, Lu XH, Tang W, Wang T (2012) Gastrointestinal symptoms predict peritonitis rates in CAPD patients. Clin Nephrol 77(4):267–274PubMedCrossRef

32.

Shu KH, Chang CS, Chuang YW, Chen CH, Cheng CH, Wu MJ, Yu TM (2009) Intestinal bacterial overgrowth in CAPD patients with hypokalaemia. Nephrol Dial Transplant 24(4):1289–1292. doi:10.1093/ndt/gfn617 PubMedCrossRef

33.

Afsar B, Elsurer R, Bilgic A, Sezer S, Ozdemir F (2010) Regular lactulose use is associated with lower peritonitis rates: an observational study. Perit Dial Int 30(2):243–246. doi:10.3747/pdi.2009.00035 PubMedCrossRef

34.

Yildiz N, Turhan P, Bilgic O, Erguven M, Candan C (2010) Vaginal dialysate leakage in a child on peritoneal dialysis. Perit Dial Int 30(6):666–667. doi:10.3747/pdi.2009.00205 PubMedCrossRef

35.

Paudel K, Namagondlu G, Samad N, McKitty K, Fan SL (2015) Lack of motivation: a new modifiable risk factor for peritonitis in patients undergoing peritoneal dialysis? J Ren Care 41(1):33–42. doi:10.1111/jorc.12101 PubMedCrossRef

36.

Satomura A, Yanai M, Fujita T, Arashima Y, Kumasaka K, Nakane C, Ito K, Fuke Y, Maruyama T, Maruyama N, Okada K, Nakayama T, Matsumoto K (2010) Peritonitis associated with Pasteurella multocida: molecular evidence of zoonotic etiology. Ther Apher Dial 14(3):373–376. doi:10.1111/j.1744-9987.2009.00788.x PubMedCrossRef

37.

Broughton A, Verger C, Goffin E (2010) Pets-related peritonitis in peritoneal dialysis: companion animals or trojan horses? Semin Dial 23(3):306–316. doi:10.1111/j.1525-139X.2010.00726.x PubMedCrossRef

38.

Rudnicki M, Kerschbaum J, Hausdorfer J, Mayer G, Konig P (2010) Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin d. Perit Dial Int 30(5):541–548. doi:10.3747/pdi.2009.00108 PubMedCrossRef

39.

Kerschbaum J, Vychytil A, Lhotta K, Prischl FC, Wiesholzer M, Machhold-Fabrizii V, Kopriva-Altfahrt G, Schwarz C, Balcke P, Oberbauer R, Kramar R, Konig P, Rudnicki M (2013) Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis. PLoS ONE 8(7):e67836. doi:10.1371/journal.pone.0067836 PubMedPubMedCentralCrossRef

40.

Qamar M, Sheth H, Bender FH, Piraino B (2009) Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives. Adv Perit Dial Conf Perit Dial 25:76–79

41.

Iyer RN, Reddy AK, Gande S, Aiyangar A (2014) Evaluation of different culture methods for the diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Microbiol Infect 20(5):O294–296. doi:10.1111/1469-0691.12402 PubMedCrossRef

42.

Barretti P, Doles JV, Pinotti DG, El Dib R (2014) Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis. BMC Infect Dis 14:445. doi:10.1186/1471-2334-14-445 PubMedPubMedCentralCrossRef

43.

Ruger W, van Ittersum FJ, Comazzetto LF, Hoeks SE, ter Wee PM (2011) Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis. Perit Dial Int 31(1):39–47. doi:10.3747/pdi.2009.00235 PubMedCrossRef

44.

Chow KM, Szeto CC, Kwan BC, Pang WF, Ma T, Leung CB, Law MC, Li PK (2014) Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis. Nephrol Dial Transplant 29(7):1438–1443. doi:10.1093/ndt/gfu033 PubMedCrossRef

45.

Liakopoulos V, Stefanidis I, Dombros NV (2010) Peritoneal dialysis glossary 2009. Int Urol Nephrol 42(2):417–423. doi:10.1007/s11255-009-9619-9 PubMedCrossRef

46.

Szeto CC, Lai KB, Kwan BC, Chow KM, Leung CB, Law MC, Yu V, Li PK (2013) Bacteria-derived DNA fragment in peritoneal dialysis effluent as a predictor of relapsing peritonitis. Clin J Am Soc Nephrol 8(11):1935–1941. doi:10.2215/CJN.02360213 PubMedPubMedCentralCrossRef

47.

Fan S, Lane C, Punzalan S (2010) Correlation of periscreen strip results and white cell count in peritoneal dialysis peritonitis. J Ren Care 36(2):90–95. doi:10.1111/j.1755-6686.2010.00150.x PubMedCrossRef

48.

Kitterer D, Latus J, Pohlmann C, Alscher MD, Kimmel M (2015) Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in GERMANY over 32 years. PLoS ONE 10(9):e0135969. doi:10.1371/journal.pone.0135969 PubMedPubMedCentralCrossRef

49.

Sutherland SM, Alexander SR, Feneberg R, Schaefer F, Warady BA, International Pediatric Peritonitis R (2010) Enterococcal peritonitis in children receiving chronic peritoneal dialysis. Nephrol Dial Transplant 25(12):4048–4054. doi:10.1093/ndt/gfq295 PubMedCrossRef

50.

Gilmore JF, Kim M, LaSalvia MT, Mahoney MV (2013) Treatment of enterococcal peritonitis with intraperitoneal daptomycin in a vancomycin-allergic patient and a review of the literature. Perit Dial Int 33(4):353–357. doi:10.3747/pdi.2012.00277 PubMedPubMedCentralCrossRef

51.

O’Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 10:19. doi:10.1186/1471-2369-10-19 PubMedPubMedCentralCrossRef

52.

Chao CT, Lee SY, Yang WS, Chen HW, Fang CC, Yen CJ, Chiang CK, Hung KY, Huang JW (2015) Viridans streptococci in peritoneal dialysis peritonitis: clinical courses and long-term outcomes. Perit Dial Int 35(3):333–341. doi:10.3747/pdi.2013.00108 PubMedPubMedCentralCrossRef

53.

Barretti P, Moraes TM, Camargo CH, Caramori JC, Mondelli AL, Montelli AC, da Cunha Mde L (2012) Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years. PLoS ONE 7(2):e31780. doi:10.1371/journal.pone.0031780 PubMedPubMedCentralCrossRef

54.

Lin SY, Ho MW, Liu JH, Liu YL, Yeh HC, Hsieh TL, Wang IK, Lin HH, Huang CC (2011) Successful salvage of peritoneal catheter in unresolved methicillin-resistant staphylococcus aureus peritonitis by combination treatment with daptomycin and rifampin. Blood Purif 32(4):249–252. doi:10.1159/000328028 PubMedCrossRef

55.

Zhang W, Wu YG, Qi XM, Dai H, Lu W, Zhao M (2014) Peritoneal dialysis-related peritonitis with Acinetobacter baumannii: a review of seven cases. Perit Dial Int 34(3):317–321. doi:10.3747/pdi.2012.00198 PubMedPubMedCentralCrossRef

56.

Liakopoulos V, Arampatzis S, Kourti P, Tsolkas T, Zarogiannis S, Eleftheriadis T, Giannopoulou M, Stefanidis I (2011) Aeromonas hydrophila as a causative organism in peritoneal dialysis-related peritonitis: case report and review of the literature. Clin Nephrol 75(S1):65–68. doi:10.2379/CNP75065 PubMed

57.

Basturk T, Koc Y, Unsal A, Ahbap E, Sakaci T, Yildiz I, Kayabasi H, Sevinc M, Kose S, Arar A (2012) Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center. Eur Rev Med Pharmacol Sci 16(12):1696–1700PubMed

58.

Nadeau JH (2015) A pre-modern and post-modern perspective of epigenetic inheritance. Semin Cell Dev Biol 43:65. doi:10.1016/j.semcdb.2015.10.006 PubMedCrossRef

59.

Levallois J, Nadeau-Fredette AC, Labbe AC, Laverdiere M, Ouimet D, Vallee M (2012) Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. Int J Infect Dis (IJID) 16(1):e41–43. doi:10.1016/j.ijid.2011.09.016 CrossRef

60.

Bhowmik D, Mahajan S, Bora M (2011) Concerns regarding the ISPD guidelines/recommendations for peritonitis due to mycobacteria. Perit Dial Int 31(3):363–364. doi:10.3747/pdi.2010.00292 Author reply 365 PubMedCrossRef

61.

Ram R, Swarnalatha G, Akpolat T, Dakshinamurty KV (2013) Mycobacterium tuberculous peritonitis in CAPD patients: a report of 11 patients and review of literature. Int Urol Nephrol 45(4):1129–1135. doi:10.1007/s11255-012-0311-0 PubMedCrossRef

62.

Renaud CJ, Subramanian S, Tambyah PA, Lee EJ (2011) The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton) 16(2):174–179. doi:10.1111/j.1440-1797.2010.01370.x CrossRef

63.

Jiang SH, Roberts DM, Dawson AH, Jardine M (2012) Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature. BMC Nephrol 13:35. doi:10.1186/1471-2369-13-35 PubMedPubMedCentralCrossRef

64.

Jiang SH, Roberts DM, Clayton PA, Jardine M (2013) Non-tuberculous mycobacterial PD peritonitis in Australia. Int Urol Nephrol 45(5):1423–1428. doi:10.1007/s11255-012-0328-4 PubMedCrossRef

65.

Song Y, Wu J, Yan H, Chen J (2012) Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 27(4):1639–1644. doi:10.1093/ndt/gfr504 PubMedCrossRef

66.

Ram R, Swarnalatha G, Dakshinamurty KV (2014) Reinitiation of peritoneal dialysis after catheter removal for refractory peritonitis. J Nephrol 27(4):445–449. doi:10.1007/s40620-014-0048-1 PubMedCrossRef

67.

Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, Clayton P, Johnson DW (2014) Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. Nephrol Dial Transplant 29(10):1940–1947. doi:10.1093/ndt/gfu050 PubMedCrossRef

68.

Szeto CC, Kwan BC, Chow KM, Pang WF, Kwong VW, Leung CB, Li PK (2011) Persistent symptomatic intra-abdominal collection after catheter removal for PD-related peritonitis. Perit Dial Int 31(1):34–38. doi:10.3747/pdi.2009.00185 PubMedCrossRef

Title: Peritoneal dialysis-related infections recommendations: 2016 update. What is new?
Authors: Vassilios Liakopoulos
Olga Nikitidou
Theofanis Kalathas
Stefanos Roumeliotis
Marios Salmas
Theodoros Eleftheriadis
Publication date: 01-12-2017
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 12/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-017-1632-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2017

The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study

Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era

Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage

Use of biological mesh in trans-anal treatment for recurrent recto-urethral fistula

Readability assessment of online patient education materials provided by the European Association of Urology

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage